Education
About Us
Working with TipRanks
Follow Us
Chemomab Therapeutics (CMMB)
NASDAQ:CMMB
CMMB Analyst Ratings
Strong Buy
3 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CMMB Stock 12 Month Forecast
Average Price Target
$29.67
▲(857.10% Upside)
| Highest Price Target$36.00 | Average Price Target$29.67 | Lowest Price Target$25.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Oppenheimer
$10→$25
Buy
706.45%
Upside
Reiterated
08/27/25
Roth MKM
$36
Buy
1061.29%
Upside
Reiterated
08/19/25
Maxim Group
$28
Buy
803.23%
Upside
Reiterated
08/15/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Oppenheimer
$10→$25
Buy
706.45%
Upside
Reiterated
08/27/25
Roth MKM
$36
Buy
1061.29%
Upside
Reiterated
08/19/25
Maxim Group
$28
Buy
803.23%
Upside
Reiterated
08/15/25
Best Analysts Covering Chemomab Therapeutics
1 Month
xxx
Success Rate
5/13 ratings generated profit
Average Return
-1.65%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 38.46% of your transactions generating a profit, with an average return of -1.65% per trade.
3 Months
xxx
Success Rate
6/13 ratings generated profit
Average Return
-7.64%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 46.15% of your transactions generating a profit, with an average return of -7.64% per trade.
1 Year
Success Rate
2/13 ratings generated profit
Average Return
-39.54%
reiterated a buy rating 9 days ago
Copying Jeff Jones's trades and holding each position for 1 Year would result in 15.38% of your transactions generating a profit, with an average return of -39.54% per trade.
2 Years
xxx
Success Rate
1/13 ratings generated profit
Average Return
-47.38%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 7.69% of your transactions generating a profit, with an average return of -47.38% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CMMB Analyst Recommendation Trends
Rating
Feb 25
Mar 25
May 25
Jun 25
Aug 25
Strong Buy
5
4
7
6
8
Buy
0
0
0
0
0
Hold
2
1
0
0
0
Sell
0
1
1
1
0
Strong Sell
0
0
0
0
0
total
7
6
8
7
8
Each month's total comprises the sum of three months' worth of ratings.
CMMB Financial Forecast
CMMB Stock Forecast FAQ
What is CMMB’s average 12-month price target, according to analysts?
Based on analyst ratings, Chemomab Therapeutics’s 12-month average price target is 29.67.
What is CMMB’s upside potential, based on the analysts’ average price target?
Chemomab Therapeutics has 857.10% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CMMB a Buy, Sell or Hold?
Chemomab Therapeutics has a consensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Chemomab Therapeutics’s price target?
The average price target for Chemomab Therapeutics is 29.67. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $36.00 ,the lowest forecast is $25.00. The average price target represents 857.10% Increase from the current price of $3.1.
The highest analyst price target is $36.00 ,the lowest forecast is $25.00. The average price target represents 857.10% Increase from the current price of $3.1.
What do analysts say about Chemomab Therapeutics?
Chemomab Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of CMMB?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.